Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children
Evaluation of Salivary Interleukin-32, Interleukin-10, Interleukin-6 and Tumor Necrosis Factor-alpha Levels in Children With Early Childhood Caries.
1 other identifier
observational
58
1 country
1
Brief Summary
This study aimed to evaluate the levels of interleukin 10, interleukin 6, interleukin 32 and tumor necrosis factor-alpha (TNF-α) in saliva of children with early childhood caries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 1, 2021
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedFirst Posted
Study publicly available on registry
July 12, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2021
CompletedOctober 21, 2021
October 1, 2021
2 months
July 1, 2021
October 20, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
IL-32
Interleukin- 32 level
Baseline
IL-10
Interleukin- 10 level
Baseline
Secondary Outcomes (2)
IL-6
Baseline
Tnf-Alpha
Baseline
Study Arms (2)
Children with early chilhood caries
Early chilhood caries group
Without early chilhood caries
Control group
Interventions
Enzim linked immunoabsorbant assay
Eligibility Criteria
28 children with early childhood caries and 28 children without caries will be collected.
You may qualify if:
- Children with untreated early chilhood caries
- Age between 3 and 6 years
You may not qualify if:
- Having a systemic problem or mental retardation
- Children with treated caries
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sultan KELEŞ
Aydin, 09100, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc.Prof.Dr.
Study Record Dates
First Submitted
July 1, 2021
First Posted
July 12, 2021
Study Start
July 1, 2021
Primary Completion
August 30, 2021
Study Completion
September 30, 2021
Last Updated
October 21, 2021
Record last verified: 2021-10